A new study reported by multiple outlets says Chinese researchers find an association between certain cholesterol-lowering statins and a higher long-term risk of erectile dysfunction (impotence). The reports focus on “two popular statins” that, according to the study, may be linked to increased risk over time. The outlets describe the research as observational in nature, based on data used to examine long-term outcomes, and they frame the findings as a potential safety signal rather than proof of a direct cause-and-effect relationship. The articles do not state that all statins carry the same risk, but instead highlight specific drugs within the statin class. The coverage emphasizes that the findings relate to erectile dysfunction risk rather than other side effects. Because the same story is presented across the two sources with limited additional detail, the exact study design, participant numbers, and which statins are involved are not fully specified in the provided text. Overall, the reporting indicates that the study raises questions about long-term sexual health outcomes for users of the identified statins and adds to ongoing discussion about medication side effects.